However, our results indicate there are two differences: 1) Pam3CSK4-induced IL-10 production is abrogated in CCR8-/- PMφ but not with R243 treatment, and 2) suppression of TNBS colitis in CCR8-/- mice is not as evident as that in R243-treated mice. The gene discussed is CCR8; the disease is colitis.